pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Tanabe Pharma Corp · news · pharmadog
← back to Tanabe Pharma Corp
News mentioning Tanabe Pharma Corp
8
stories
19h
Shionogi pays $2B to acquire a rare disease startup
biopharma dive
5d
Kallyope rebrands after Novo obesity deal, gets $94M for Phase 3 migraine drug
endpoints
8d
Tolerance continues thymus-focused deals with $560M pact for Tanabe's clinical-stage IL-33 drug
fiercebiotech
Aug 18, 26
Leo Pharma buys rare skin disease drug in $435M deal
biopharma dive
Aug 18, 26
LEO adds to dermatology portfolio with $435M deal for late-stage rare disease drug
biospace
Aug 18, 26
Leo Pharma to license Tanabe’s rare disease drug for pain with sun exposure
endpoints
Aug 17, 26
Leo ‘really strengthening’ pipeline with $435M deal for Tanabe rare skin disease drug awaiting FDA nod
fiercebiotech
Jun 3, 26
Mineralys makes money moves before looming hypertension approval
endpoints
